SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending as the community reacts to news of a government directive to purchase $200 billion in mortgage bonds, aiming to significantly lower rates. This development is sparking widespread bullish sentiment, with many anticipating a revitalized housing market, increased transaction volume, and potential for a substantial short squeeze on the stock.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies (RKT) is trending following news of former President Trump's plans to stimulate the housing market, including instructing representatives to buy $200 billion in mortgage bonds and potentially banning institutional home purchases. This has ignited community discussion around an impending refinance boom and increased housing affordability, positioning RKT's integrated mortgage and real estate platform for a significant re-rating and potential new highs. Investors are actively debating the magnitude of this positive catalyst on RKT's business model.

flyExclusive, Inc. engages in owning and operating jet aircraft for private jet passengers. It manages all aspects of the customer experience, in-house maintenance, repair, and overhaul services, including paint, interiors, and avionics capabilities. The company was founded by Thomas James Segrave, Jr. in 2015 and is headquartered in Kinston, NC.

flyExclusive Inc. - Ordinary Shares - Class A

flyExclusive is experiencing a surge in attention following its announcement as an authorized Starlink Aviation dealer, which allows the company to install high-speed internet on its private jet fleet and for third-party clients. This development is fueling widespread discussion and speculative trading activity, with the community weighing its potential for new revenue streams against market concerns regarding recent stock offerings.

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Aclarion Inc

Aclarion Inc. (ACON) is trending after releasing its 2025 update and 2026 corporate outlook, highlighting triple-digit growth for its Nociscan AI back pain platform and a strong financial position with no debt. The community is actively discussing the stock's low float and substantial cash per share, leading to speculation about a significant short squeeze reminiscent of other recent low-float runners. However, some investors remain cautious, citing the company's history of reverse splits and potential dilution concerns.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae (FNMA) is trending due to recent political statements outlining a directive for the entity to utilize its substantial cash reserves, including $200 billion, to purchase mortgage bonds aimed at lowering interest rates. This move is widely discussed within the community as a significant progression towards resolving long-standing issues and potentially paving the way for its release from conservatorship and eventual public offering. Investors are actively debating the implications of this strategy for the housing market and the entity's future, with many anticipating a major shift.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending following disappointing preliminary Q4 results and a significantly lowered DefenCath revenue guidance for 2026 and 2027, primarily due to the anticipated expiration of TDAPA funding, triggering a sharp sell-off and strong community frustration with management. Despite the immediate negative reaction, many bulls see the dip as an overreaction and a buying opportunity, emphasizing that the guidance is conservative and excludes potential upsides from new customers, upcoming legislation like the Kidney Care Access Protection Act, and growth from the broader Melinta Therapeutics portfolio.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The iShares Russell 2000 ETF (IWM) is a major focus as small-cap stocks are demonstrating significant relative strength, breaking out to new all-time highs and sharply outperforming larger indices. The community is actively discussing whether this powerful "risk-on" surge is sustainable, especially with market participants awaiting critical economic reports and a potential Supreme Court tariff ruling that could influence future market sentiment and liquidity.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is trending on confirmed reports that its subsidiary, Airobotics, has been selected as the prime contractor for Israel's significant drone hive border security project. This pivotal role, alongside broader discussions of increased defense spending and strategic partnerships, is fueling immense community optimism regarding its future in autonomous defense systems. Many investors are anticipating continued growth, driven by strong institutional interest and the potential for a "drone super-cycle."

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is a top trending stock, with investors closely watching its expanding AI server demand and strategic position in the fast-growing artificial intelligence infrastructure market. Community discussions highlight accusations of market manipulation by analysts and debates over potential margin impacts from memory costs, with many viewing the company as undervalued amidst its strong order backlog.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Acumen Pharmaceuticals (NASDAQ:ABOS) CFO Matt Zuga Sells 5,100 Shares

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) CFO Matt Zuga sold 5,100 shares of the business's stock in a transaction dated Tuesday, January 6th. The stock was sold at an average...

Acumen Pharmaceuticals (NASDAQ:ABOS) Upgraded at Wall Street Zen

Wall Street Zen upgraded Acumen Pharmaceuticals from a "sell" rating to a "hold" rating in a research note on Sunday...

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the five research firms that are currently covering the company...

Acumen Pharmaceuticals (NASDAQ:ABOS) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen downgraded Acumen Pharmaceuticals from a "hold" rating to a "sell" rating in a research report on Saturday...

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Given Consensus Rating of "Moderate Buy" by Brokerages

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five research firms that are covering the company, MarketBeat reports. One...

Acumen Pharmaceuticals (NASDAQ:ABOS) Price Target Cut to $8.00 by Analysts at Bank of America

Bank of America cut their price objective on shares of Acumen Pharmaceuticals from $9.00 to $8.00 and set a "buy" rating on the stock in a research report on Tuesday...

Acumen Pharmaceuticals (NASDAQ:ABOS) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen upgraded Acumen Pharmaceuticals from a "strong sell" rating to a "hold" rating in a report on Saturday...

Acumen Pharmaceuticals (NASDAQ:ABOS) Releases Quarterly Earnings Results, Beats Expectations By $0.19 EPS

Acumen Pharmaceuticals (NASDAQ:ABOS - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.44) EPS for the quarter, beating analysts' consensus estimates of...

Preview: Acumen Pharmaceuticals's Earnings

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Newton, MA.

Acumen Pharmaceuticals Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.45	--	--	N/A
Q3 '25	-$0.60	-$0.44	27.03%	BEAT
Q2 '25	-$0.49	-$0.68	-39.17%	MISSED
Q1 '25	-$0.73	-$0.48	33.92%	BEAT
Q4 '24	-$0.51	-$0.62	-20.62%	MISSED

ABOS
Acumen Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest ABOS News

ABOSAcumen Pharmaceuticals Inc